CN1380082A - Chinese medicine for curing female chronic inflammation - Google Patents

Chinese medicine for curing female chronic inflammation Download PDF

Info

Publication number
CN1380082A
CN1380082A CN02112693A CN02112693A CN1380082A CN 1380082 A CN1380082 A CN 1380082A CN 02112693 A CN02112693 A CN 02112693A CN 02112693 A CN02112693 A CN 02112693A CN 1380082 A CN1380082 A CN 1380082A
Authority
CN
China
Prior art keywords
chinese medicine
medicine
chronic inflammation
treatment
fructus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN02112693A
Other languages
Chinese (zh)
Other versions
CN1160102C (en
Inventor
沈华志
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB021126933A priority Critical patent/CN1160102C/en
Publication of CN1380082A publication Critical patent/CN1380082A/en
Application granted granted Critical
Publication of CN1160102C publication Critical patent/CN1160102C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The Chinese medicine for curing gynecological chronic inflammation is made up by using 17 Chinese medicinal materials of sargentodoxa stem, baijiang, moutan root bark, gardenia fruit, phellodendron bark, coix seed and others. Said medicine has no side effect and its therapeutic effect is good.

Description

The Chinese medicine of treatment female chronic inflammation
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of female chronic inflammation.
Background technology
In recent years, because artificial abortion, the extensive use of medicine stream, the growing and stretch of vile practices such as prostitution and whoring, and other system transmission of disease, diffusion etc., the sickness rate of female reproductive system infectious disease is obviously risen, through the adult women of clinical statistics about 70% in various degree the chronic genital disease of suffering from is arranged all, as: pelvic inflammatory disease, pelvic cavity hydrops, adnexitis, endometritis, the endometrium adhesion, ovarian cyst, cervical erosion, salpingitis, hydrosalpinx, obstruction of fallopian tube and infertility of causing by above-mentioned disease etc., health hazard to friend women is very big, and does not have ideal medicament thoroughly to effect a radical cure so far.
The chronic inflammatory disease of female reproductive system, doctor trained in Western medicine thinks because unclean sexual intercourse, artificial abortion, medicine stream and clinical examination, the transmission of infection institute of the not tight or adjacent internal organs of sterilization extremely in the treatment operating process, in the test chamber check, can find staphylococcus aureus, escherichia coli, gonorrhea diplococcus, chlamydia, mycoplasma etc., employed medicine mainly is a Novel Quinolone class antibacterial, take by the course of treatment, for acute gynecological inflammation or slighter pelvic inflammatory disease, curative effects such as adnexitis still can, but for chronic or more serious gynecological inflammation, then curative effect is very little or invalid, clothes can produce drug resistance for a long time, and are also fairly obvious to the infringement of hepatic and renal function.As: the ofloxacin tablet, to take medicine ten days, drug withdrawal seven days is a course of treatment, generally need take 2~4 courses of treatment, the course of treatment is long; The standard treatment of 2~4 courses of treatment of Novel Quinolone class antibacterial, clinical cure rate only 36%, 6 months relapse rates 62% wherein, weak curative effect; Take Novel Quinolone class antibacterial, 2~3 courses of treatment, untoward reaction such as headache in various degree, dizzy, erythra, cardiopalmus, insomnia promptly appearred in the patient, part patient also have stronger feel sick, gastrointestinal symptom such as vomiting; Taking Novel Quinolone class antibacterial, is that conscious curative effect descends since second course of treatment generally, and 3~4 courses of treatment, then curative effect was successively decreased, and reused, and produced drug resistance.And the use of Novel Quinolone class antibacterial generally is no more than 2 months the course of treatment, otherwise side effect is very big, and curative effect then falls far short.
The traditional Chinese medical science is thought, the chronic inflammatory disease of gynaecologic reproductive system belongs to damp-heat in lower-JIAO, hyperactivity of fire caused by deficiency of YIN, the strongly fragrant living heat of a specified duration of noxious dampness, heat in blood stagnation of QI institute extremely, clinical clearing away heat and cooling blood, eliminating damp, detoxifying, the soothing the liver methods that clear away heart-fire of adopting more, and square medicine stresses profit clearly more.Chinese patent medicine SANJIN PIAN commonly used, women scorching convalescence tablet, " Fubao " instant granular preparation, gynaecologic Fenqing pill, FUKE QIANJIN PIAN, FULE CHONGJI, FUYANJING JIAONANG, fuyanping capsules, HUAHONG PIAN etc.Through clinical statistics, above Chinese patent medicine uses 30~90 days cure rate average about 20%, total effective rate average out to about 61%, weak curative effect; General patient take Chinese patent medicine on average the phase of taking effect be 15~20 days, the basic healing then needs 3~6 months, even the longer time, the course of treatment is long; Because the course of treatment is long, medical expense is higher relatively, and quite a few patient can't bear, and the Halfway Stopping medication.
Technical scheme
The present invention is for solving the problem that prior art exists, summing up on the empirical basis of forefathers, through nearly thousand times drug screening, injectivity optimizing, adjustment, contrast and ten thousand routine patients' clinical verification, provide the Chinese medicine of the treatment female chronic inflammation of a kind of curative effect height, short treating period.
Prescription of the present invention is as follows:
The Chinese medicine of treatment female chronic inflammation, it is characterized in that: its active component is the extract of being made by the herbal raw material of following consumption proportion
Caulis Sargentodoxae 20~30 Herba Patriniae 20~30
Cortex Moutan 10~15 mountain masts 10~15 Cortex Phellodendris 10~20
SEMEN COICIS 10~20 Spina Gleditsiae 15~25 Fructus Akebiaes 10~15
Rhizoma Atractylodis 10~15 Herba Lycopi 10~15 Rhizoma Chuanxiongs 10~15
Flos Carthami 10~15 Eupolyphaga Seu Steleophagas 10~20 Fructus Liquidambaris 15~25
Radix Astragali Preparata 15~25 Radix Angelicae Sinensis 15~25 Semen Cuscutae 10~25
Among the side of the present invention, Caulis Sargentodoxae, Herba Patriniae, Cortex Moutan, mountain mast, Cortex Phellodendri have heat-clearing and toxic substances removing, removing heat from blood dampness, and through sick institute is monarch drug, are the keys that solves female chronic inflammation; Semen Coicis, Spina Gleditsiae, Herba Lycopi, Fructus Liquidambaris energy removing toxic substances and promoting pus discharge, inducing diuresis to remove edema, the cytothesis of help swelling reverses, and is ministerial drug; Flos Carthami, Eupolyphaga Seu Steleophaga, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Herba Lycopi can blood circulation promoting and blood stasis dispelling, the promoting the circulation of QI to induce diuresis that can nourish blood is again helped the monarch and his subjects mutually, can improve local circulation, promote focus to absorb, and improve curative effect, shorten the course of treatment.
The traditional Chinese medical science thinks that prolonged illness must be empty, the Radix Astragali, Radix Angelicae Sinensis, Semen Cuscutae, Fructus Akebiae energy strengthening vital QI to eliminate pathogenic factors, dispersing the stagnated live-QI to relieve the stagnation of QI, tonify without causing stagnation in the side, enhancing human body immunity power.
Chinese medicine of the present invention has the advantage of several respects:
One, Chinese medicine of the present invention course of treatment is one month, course cure rate at the cure rate of 82%, two course of treatment 92%, short treating period;
Two, Chinese medicine taking dose of the present invention and the similar Chinese patent medicine dosage of comparing is little, every day dosage only 20g (crude drug content) can reach expection;
Three, this Chinese medicine through animal model routinely Ji Liang ?10 times take, take continuously and do not see toxic and side effects in 12 months, take safe and reliable for a long time;
Four, the raw material of Chinese medicine kind that this Chinese medicine adopted is common Chinese herbal medicine, easily gathers, and the medicine source is extensive, easy-to-collection and infusion;
Five, the used Chinese herbal medicine of this Chinese medicine is cheap, and through measuring and calculating, every day, the medical herbs cost about 2 yuan, was 15%~20% of a similar Chinese patent medicine only.
The specific embodiment
Below in conjunction with embodiment the present invention is further described.
Embodiment 1
Prescription of the present invention one is as follows:
Caulis Sargentodoxae 20 Herba Patriniae 20
Cortex Moutan 10 mountain masts 10 Cortex Phellodendris 10
SEMEN COICIS 10 Spina Gleditsiae 15 Fructus Akebiaes 10
Rhizoma Atractylodis 10 Herba Lycopi 10 Rhizoma Chuanxiongs 10
Flos Carthami 10 Eupolyphaga Seu Steleophagas 10 Fructus Liquidambaris 25
Radix Astragali Preparata 15 Radix Angelicae Sinensis 15 Semen Cuscutae 15
Embodiment 2 prescription of the present invention two is as follows: Caulis Sargentodoxae 25 Herba Patriniae 25 Cortex Moutans 10 mountain masts 15 Cortex Phellodendris 15 SEMEN COICIS 15 Spina Gleditsiae 20 Fructus Akebiaes 15 Rhizoma Atractylodis 10 Herba Lycopi 12 Rhizoma Chuanxiongs 12 Flos Carthamis 10 Eupolyphaga Seu Steleophagas 15 Fructus Liquidambaris 20 Radix Astragali Preparatas 20 Radix Angelicae Sinensis 20 Semen Cuscutae 20
Embodiment 3 prescription of the present invention three is as follows: Caulis Sargentodoxae 30 Herba Patriniae 30 Cortex Moutans 15 mountain masts 15 Cortex Phellodendris 20 SEMEN COICIS 20 Spina Gleditsiae 25 Fructus Akebiaes 10 Rhizoma Atractylodis 10 Herba Lycopi 10 Rhizoma Chuanxiongs 10 Flos Carthamis 10 Eupolyphaga Seu Steleophagas 10 Fructus Liquidambaris 15 Radix Astragali Preparatas 15 Radix Angelicae Sinensis 15 Semen Cuscutae 10
Embodiment 4 prescription of the present invention four is as follows: Caulis Sargentodoxae 20 Herba Patriniae 30 Cortex Moutans 12 mountain masts 12 Cortex Phellodendris 12 SEMEN COICIS 12 Spina Gleditsiae 16 Fructus Akebiaes 12 Rhizoma Atractylodis 12 Herba Lycopi 12 Rhizoma Chuanxiongs 12 Flos Carthamis 12 Eupolyphaga Seu Steleophagas 12 Fructus Liquidambaris 16 Radix Astragali Preparatas 16 Radix Angelicae Sinensis 16 Semen Cuscutae 12 these form of Chinese drug can be electuary, also can be tablet, also can be oral liquid etc.
With the electuary is example, gets above-mentioned Chinese medicine, removes impurity, cleans and dries; Then effective component extracting adds firming agent in the effective ingredient that extracts, and solidified forming is an electuary, packs by the specification of every bag of 20g, puts in storage to be finished product.

Claims (1)

  1. The Chinese medicine of 1 treatment female chronic inflammation, it is characterized in that: its active component is the extract of being made by the herbal raw material of following consumption proportion
    Caulis Sargentodoxae 20~30 Herba Patriniae 20~30
    Cortex Moutan 10~15 mountain masts 10~15 Cortex Phellodendris 10~20
    SEMEN COICIS 10~20 Spina Gleditsiae 15~25 Fructus Akebiaes 10~15
    Rhizoma Atractylodis 10~15 Herba Lycopi 10~15 Rhizoma Chuanxiongs 10~15
    Flos Carthami 10~15 Eupolyphaga Seu Steleophagas 10~20 Fructus Liquidambaris 15~25
    Radix Astragali Preparata 15~25 Radix Angelicae Sinensis 15~25 Semen Cuscutae 10~25
CNB021126933A 2002-02-22 2002-02-22 Chinese medicine for curing female chronic inflammation Expired - Fee Related CN1160102C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB021126933A CN1160102C (en) 2002-02-22 2002-02-22 Chinese medicine for curing female chronic inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021126933A CN1160102C (en) 2002-02-22 2002-02-22 Chinese medicine for curing female chronic inflammation

Publications (2)

Publication Number Publication Date
CN1380082A true CN1380082A (en) 2002-11-20
CN1160102C CN1160102C (en) 2004-08-04

Family

ID=4742187

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021126933A Expired - Fee Related CN1160102C (en) 2002-02-22 2002-02-22 Chinese medicine for curing female chronic inflammation

Country Status (1)

Country Link
CN (1) CN1160102C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1304030C (en) * 2003-03-06 2007-03-14 韩小坛 Medicine for menstrual disorder and leukorrhagia
CN101352545B (en) * 2008-09-11 2010-12-08 刘运波 Chinese medicine for treating pelvic inflammation
CN104383454A (en) * 2014-12-04 2015-03-04 庄成龙 Traditional Chinese medicine enema mixture for treating gynecological diseases and preparation method of traditional Chinese medicine enema mixture
CN105076702A (en) * 2015-09-06 2015-11-25 贵州奎香满园食品有限公司 Traditional Chinese medicine additive for egg-laying quail feed

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1304030C (en) * 2003-03-06 2007-03-14 韩小坛 Medicine for menstrual disorder and leukorrhagia
CN101352545B (en) * 2008-09-11 2010-12-08 刘运波 Chinese medicine for treating pelvic inflammation
CN104383454A (en) * 2014-12-04 2015-03-04 庄成龙 Traditional Chinese medicine enema mixture for treating gynecological diseases and preparation method of traditional Chinese medicine enema mixture
CN105076702A (en) * 2015-09-06 2015-11-25 贵州奎香满园食品有限公司 Traditional Chinese medicine additive for egg-laying quail feed

Also Published As

Publication number Publication date
CN1160102C (en) 2004-08-04

Similar Documents

Publication Publication Date Title
CN1899598A (en) Combined medicine for preventing and treating rheumatism, rheumatoid, protrusion of intervertebral disc and hyperosteogeny
CN1814245A (en) Chinese medicine remedy for treating cervical vertebra disease
CN101647924A (en) Traditional Chinese medicine formula for treating chronic pelvic inflammation in oral-taking way
CN102961483A (en) Traditional Chinese medicine composition for treating pain in waist and lower extremities and preparation method thereof
CN1517119A (en) Medicinal wine or liquid for treating cold
CN101991794A (en) Chinese traditional medicine preparation for treating eczema
CN101703709A (en) Chinese medicinal preparation for treating rheumatoid arthritis
CN1478525A (en) Medicated wine for treating traumatic injury
CN1160102C (en) Chinese medicine for curing female chronic inflammation
CN101843804A (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN100579544C (en) Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof
CN101214365A (en) Chinese medicine composing prescription for treating mastoproliferation
CN100386107C (en) Rhinitis treating medicine bolus
CN1775275A (en) External-use lotion of Chinese medicine for treating skin disease and perineum disease
CN102205096A (en) Medicament for treating adnexitis and pelvic inflammation
CN1312085A (en) Dermatosis treating medicine
CN1181879C (en) Analgestic plaster
CN104784518A (en) Traditional Chinese medicine preparation for treating diabetes
CN1269520C (en) Medicine for treating human lithic disease
CN102366591B (en) Chinese herbal medicinal wine for treating rheumatoid and rheumatoid arthritis and its preparation method
CN103550510A (en) Lotion for treating various vaginitis
CN101288760B (en) Externally-used drug for treating appendicitis
CN101850046B (en) Chinese medicament for treating chronic hepatitis
CN102085350A (en) Medicament for treating arthritis and preparation method thereof
CN101843707B (en) Chinese medicament for treating chronic hepatitis

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee